Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Research

Health-related risk behaviors among U.S. childhood cancer survivors: a nationwide estimate

Authors: Van T. Nghiem, Jing Jin, Stephen T. Mennemeyer, F. Lennie Wong

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

Childhood cancer survivors (CCS) are subject to a substantial burden of treatment-related morbidity. Engaging in health protective behaviors and eliminating risk behaviors are critical to preventing chronic diseases and premature deaths. This study is aimed to provide updated information on currently smoking, physical inactivity, binge drinking patterns and associated factors among CCS using a nationwide dataset.

Methods

We constructed a sample of CCS (cancer diagnosis at ages < 21y) and healthy controls (matched on age, sex, residency, race/ethnicity) using 2020 Behavioral Risk Factor Surveillance System. We used Chi-square tests and Wilcoxon rank-sum test to examine differences in sociodemographics and clinical characteristics between two groups. Logistic, ordinal regression and multivariable models (conditional models for matching) were used to determine factors associated with risk behaviors.

Results

The final sample (18-80y) included 372 CCS and 1107 controls. Compared to controls, CCS had a similar proportion of binge drinking (~ 18%) but higher prevalence of currently smoking (26.6% vs. 14.4%, p < 0.001), physical inactivity (23.7% vs. 17.7%, p = 0.012), and of having 2-or-3 risk behaviors (17.2% vs. 8.1%, p < 0.001). Younger age, lower educational attainment, and having multiple chronic health conditions were associated with engaging in more risk behaviors among CCS. Females, compared to male counterparts, had lower odds of binge drinking (adjusted odds ratio (aOR) = 0.30, 95% confidence interval (CI): 0.16–0.57) among CCS but not in all sample. Having multiple chronic health conditions increased odds of both currently smoking (aOR = 3.52 95%CI: 1.76–7.02) and binge drinking (aOR = 2.13 95%CI: 1.11–4.08) among CCS while it only increased odds of currently smoking in all sample.

Discussion

Our study provided risk behavior information for wide age-range CCS, which is currently lacking. Every one in four CCS was currently smoking. Interventions targeting risk behavior reduction should focus on CCS with multiple chronic health conditions.
Appendix
Available only for authorised users
Literature
19.
go back to reference Li Y, Graubard BI, DiGaetano R. Weighting methods for population-based case–control studies with complex sampling. J R Stat Soc: Ser C: Appl Stat. 2011;60(2):165–85.MathSciNetCrossRef Li Y, Graubard BI, DiGaetano R. Weighting methods for population-based case–control studies with complex sampling. J R Stat Soc: Ser C: Appl Stat. 2011;60(2):165–85.MathSciNetCrossRef
20.
go back to reference Clarke S-A, Eiser C. Health behaviours in childhood cancer survivors: a systematic review. Eur J Cancer. 2007;43(9):1373–84.CrossRefPubMed Clarke S-A, Eiser C. Health behaviours in childhood cancer survivors: a systematic review. Eur J Cancer. 2007;43(9):1373–84.CrossRefPubMed
50.
go back to reference Ford JS, Ostroff JS. Health behaviors of childhood cancer survivors: what we’ve learned. J Clin Psychol Med Settings. 2006;13(2):144–60.CrossRef Ford JS, Ostroff JS. Health behaviors of childhood cancer survivors: what we’ve learned. J Clin Psychol Med Settings. 2006;13(2):144–60.CrossRef
Metadata
Title
Health-related risk behaviors among U.S. childhood cancer survivors: a nationwide estimate
Authors
Van T. Nghiem
Jing Jin
Stephen T. Mennemeyer
F. Lennie Wong
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-11894-7

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine